Research Article
Analysis of Ratio and Financial Performance of Open Company Pharmaceutical Industry Which has Been Listing in Indonesia Stock Exchange (Case Study in Pharmaceutical Company PT. Kimia Farma.Tbk)
@INPROCEEDINGS{10.4108/eai.17-7-2020.2303065, author={Tri Wartono and Muliahadi Tumanggor and Bulan Oktrima and Veta Lidya Delimah Pasaribu}, title={Analysis of Ratio and Financial Performance of Open Company Pharmaceutical Industry Which has Been Listing in Indonesia Stock Exchange (Case Study in Pharmaceutical Company PT. Kimia Farma.Tbk)}, proceedings={Proceedings of the 1st International Conference on Economics Engineering and Social Science, InCEESS 2020, 17-18 July, Bekasi, Indonesia}, publisher={EAI}, proceedings_a={INCEESS}, year={2021}, month={1}, keywords={financial ratios financial performance industry average ratio time series analysis cross sectional analysis common size analysis and pharmacy industry average ratios}, doi={10.4108/eai.17-7-2020.2303065} }- Tri Wartono
Muliahadi Tumanggor
Bulan Oktrima
Veta Lidya Delimah Pasaribu
Year: 2021
Analysis of Ratio and Financial Performance of Open Company Pharmaceutical Industry Which has Been Listing in Indonesia Stock Exchange (Case Study in Pharmaceutical Company PT. Kimia Farma.Tbk)
INCEESS
EAI
DOI: 10.4108/eai.17-7-2020.2303065
Abstract
The financial performance of a company is one indication, whether the company has been running and developing in accordance with the demands and rules of good management. One of them is PT. Kimia Farma, Tbk for the past three years. The concept of financial performance analysis by evaluating past performance and then predicting future performance Analysis Stages include: (1) Time series analysis, which is calculating financial ratios and comparing from year to year for the company (2) Common Size Analysis, namely the presentation of the balance sheet reporting percentage (Common Size Balance Sheat), income statement or loss presentation (Common Size Income Steatment) and cash flow statement (Common Siza Cash Flow). (3) Cross Sectional Analysis that is by comparing the company's financial ratios with the average ratio industry (Similar Companies) (4) Calculation and preparation of the average ratio of the pharmaceutical industry. In line with the decline in performance of PT. Kimia Farma, when compared to the industry average ratio, turns out that all ratios are below the industry average ratio. Only one indicator is ROE which is greater than the industry average ratio. This is confirmed that the assets of PT. Kimia Farma, Tbk is far less productive than the assets of similar companies with low asset turnover.
